SE9600647D0 - Ny användning - Google Patents
Ny användningInfo
- Publication number
- SE9600647D0 SE9600647D0 SE9600647A SE9600647A SE9600647D0 SE 9600647 D0 SE9600647 D0 SE 9600647D0 SE 9600647 A SE9600647 A SE 9600647A SE 9600647 A SE9600647 A SE 9600647A SE 9600647 D0 SE9600647 D0 SE 9600647D0
- Authority
- SE
- Sweden
- Prior art keywords
- mucous membranes
- new use
- protein
- tropism
- immunogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
DE69726712T DE69726712T2 (de) | 1996-02-21 | 1997-02-20 | Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält |
EP97905541A EP0889736B1 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and an antigen |
AU22385/97A AU719084B2 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
NZ331403A NZ331403A (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
AT97905541T ATE255905T1 (de) | 1996-02-21 | 1997-02-20 | Iscom oder iscom-matrix, welche einen gegen die schleimhaut gerichteten wirkstoff und ein antigen enthält |
PCT/SE1997/000289 WO1997030728A1 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
ES97905541T ES2210495T3 (es) | 1996-02-21 | 1997-02-20 | Iscom o matriz de iscom que comprende una sustancia dirigida especificamente a las mucosas y un antigeno. |
CA002247522A CA2247522C (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
JP9530070A JP2000504746A (ja) | 1996-02-21 | 1997-02-20 | 粘液ターゲティング物質、および抗原を随時含むイスコムまたはイスコム―マトリックス |
DK97905541T DK0889736T3 (da) | 1996-02-21 | 1997-02-20 | Iscom eller iscom-matrix, der omfatter et stof, der retter sig mod mucus, og et antigen |
US09/137,236 US6607732B2 (en) | 1996-02-21 | 1998-08-20 | ISCOM or ISCOM-matrix comprising a mucous targetting substance and an antigen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9600647D0 true SE9600647D0 (sv) | 1996-02-21 |
Family
ID=20401481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9600647A SE9600647D0 (sv) | 1996-02-21 | 1996-02-21 | Ny användning |
Country Status (12)
Country | Link |
---|---|
US (1) | US6607732B2 (xx) |
EP (1) | EP0889736B1 (xx) |
JP (1) | JP2000504746A (xx) |
AT (1) | ATE255905T1 (xx) |
AU (1) | AU719084B2 (xx) |
CA (1) | CA2247522C (xx) |
DE (1) | DE69726712T2 (xx) |
DK (1) | DK0889736T3 (xx) |
ES (1) | ES2210495T3 (xx) |
NZ (1) | NZ331403A (xx) |
SE (1) | SE9600647D0 (xx) |
WO (1) | WO1997030728A1 (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
NZ508927A (en) | 1998-05-22 | 2003-12-19 | Ottawa Health Research Inst | Methods and products for inducing mucosal immunity |
US7041296B1 (en) * | 1999-11-12 | 2006-05-09 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of treating inflammatory bowel disease using cholera toxin B subunit |
US7713942B2 (en) * | 2001-04-04 | 2010-05-11 | Nordic Vaccine Technology A/S | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides |
SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
SE0301998D0 (sv) * | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
EP1838341B1 (en) | 2005-01-20 | 2013-08-14 | Isconova AB | Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
CA2698392C (en) | 2007-09-04 | 2019-12-03 | Baoming Jiang | Thermal inactivation of rotavirus |
GB0803076D0 (en) | 2008-02-20 | 2008-03-26 | Univ Ghent | Mucosal Membrane Receptor and uses thereof |
ES2325243B1 (es) * | 2008-02-27 | 2011-05-04 | Universidad De Granada | Antigeno recombinante. |
JP6133207B2 (ja) | 2010-07-23 | 2017-05-24 | イスコノバ アーベー | インフルエンザワクチン |
WO2012158643A1 (en) | 2011-05-13 | 2012-11-22 | Ah Usa 42 Llc | Hendra and nipah virus g glycoprotein immunogenic compositions |
DK3311827T3 (da) | 2011-10-03 | 2023-04-03 | Canqura Oncology Ab | Nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf som bærere for amfipatiske eller hydrofobe molekyler inden for det medicinske område, inklusiv cancerbehandling, samt fødevarerelaterede forbindelser |
AU2014214844B2 (en) | 2013-02-07 | 2017-12-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
WO2014163558A1 (en) | 2013-04-01 | 2014-10-09 | Moreinx Ab | Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds |
WO2015095012A1 (en) | 2013-12-16 | 2015-06-25 | Zoetis Llc | Hendra and nipah virus g glycoprotein immunogenic compositions |
EP3344291A4 (en) | 2015-09-03 | 2019-04-10 | Novavax, Inc. | VACCINE COMPOSITIONS WITH IMPROVED STABILITY AND IMMUNOGENICITY |
KR20210004959A (ko) | 2018-03-19 | 2021-01-13 | 노바백스, 인코포레이티드 | 다가 인플루엔자 나노입자 백신 |
US10953089B1 (en) | 2020-01-27 | 2021-03-23 | Novavax, Inc. | Coronavirus vaccine formulations |
GB202209588D0 (en) | 2022-06-29 | 2022-08-10 | Plant Bioscience Ltd | Methods and compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
-
1996
- 1996-02-21 SE SE9600647A patent/SE9600647D0/xx unknown
-
1997
- 1997-02-20 NZ NZ331403A patent/NZ331403A/en not_active IP Right Cessation
- 1997-02-20 ES ES97905541T patent/ES2210495T3/es not_active Expired - Lifetime
- 1997-02-20 AT AT97905541T patent/ATE255905T1/de not_active IP Right Cessation
- 1997-02-20 CA CA002247522A patent/CA2247522C/en not_active Expired - Lifetime
- 1997-02-20 DK DK97905541T patent/DK0889736T3/da active
- 1997-02-20 EP EP97905541A patent/EP0889736B1/en not_active Expired - Lifetime
- 1997-02-20 WO PCT/SE1997/000289 patent/WO1997030728A1/en active IP Right Grant
- 1997-02-20 AU AU22385/97A patent/AU719084B2/en not_active Expired
- 1997-02-20 DE DE69726712T patent/DE69726712T2/de not_active Expired - Lifetime
- 1997-02-20 JP JP9530070A patent/JP2000504746A/ja active Pending
-
1998
- 1998-08-20 US US09/137,236 patent/US6607732B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2210495T3 (es) | 2004-07-01 |
NZ331403A (en) | 2000-02-28 |
US6607732B2 (en) | 2003-08-19 |
EP0889736A1 (en) | 1999-01-13 |
JP2000504746A (ja) | 2000-04-18 |
CA2247522C (en) | 2009-12-29 |
AU2238597A (en) | 1997-09-10 |
AU719084B2 (en) | 2000-05-04 |
ATE255905T1 (de) | 2003-12-15 |
CA2247522A1 (en) | 1997-08-28 |
US20020131982A1 (en) | 2002-09-19 |
EP0889736B1 (en) | 2003-12-10 |
DE69726712D1 (de) | 2004-01-22 |
WO1997030728A1 (en) | 1997-08-28 |
DK0889736T3 (da) | 2004-04-19 |
DE69726712T2 (de) | 2004-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9600647D0 (sv) | Ny användning | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
DE69019164T2 (de) | Verbessertes meningokokkale polysaccharidkonjugatvakzin. | |
MY113428A (en) | Hepatitis b vaccine | |
EP0955059A3 (en) | Vaccines containing a saponin and a sterol | |
BR9814483A (pt) | "vacina" | |
BR0014282A (pt) | Vacinas | |
GB2303854B (en) | Helicobacter proteins and vaccines | |
CY1107457T1 (el) | Εμβoλιο κατa του hpv | |
NO982497L (no) | Vaksine-sammensetninger for inntak gjennom nesen | |
MX9203808A (es) | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. | |
TR199501635A1 (tr) | Solunum yolu ile alinan terapötik preparatlar. | |
AU8113591A (en) | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties | |
BR9610679A (pt) | Antígenos de leishmania para uso na terapia e disgnose da leishmaniose | |
ATE249841T1 (de) | Immunogene zubereitungen | |
FR2669346B1 (fr) | Vaccin a poxvirus recombinant contre le virus de la rougeole. | |
AU1801195A (en) | Antigenic preparation for treatment or prevention of helicobacter infection | |
IT1234817B (it) | Tappeto per idromassaggi. | |
FI915702A0 (fi) | Peptider och daerav erhaollna antikroppar foer diagnos av vaccination emot htlv-1 infektion. | |
FR2715304B1 (fr) | Vaccin anti-allergique. | |
WO2001034185A3 (en) | Induction of mucosal immunity by vaccination via the skin route | |
DE68906030T2 (de) | Entlueftung eines antischleuderbremssystems. | |
WO2001037862A3 (en) | A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias | |
ES2082221T3 (es) | Neuraminidasa y galactosa-oxidasa en calidad de adyuvante de vacunas. | |
AU1825895A (en) | Retroviral vaccines, vaccination and immune-therapy for retroviral infections |